All data are based on the daily closing price as of January 19, 2026
c

Chong Kun Dang Pharmaceutical

185750.KO
56.37 USD
-0.23
-0.41%

Overview

Last close
56.37 usd
Market cap
742.70M usd
52 week high
90.07 usd
52 week low
48.18 usd
Target price
76.46 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.6529
Price/Book Value
1.1642
Enterprise Value
794.27M usd
EV/Revenue
0.6974
EV/EBITDA
10.5474

Key financials

Revenue TTM
1.14B usd
Gross Profit TTM
356.66M usd
EBITDA TTM
72.97M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
1.09B usd
Net debt
58.95M usd

About

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
  • Symbol
    185750.KO
  • Exchange
    KO
  • Isin
    KR7185750007
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Young-Joo Kim
  • Headquarter
    Seoul
  • Web site
    https://www.ckdpharm.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top